Dr. Clyde Aulgin Collins, MD

Dr. Collins practices at Baylor Scott & White Medical Center - Frisco in Frisco, Texas, part of Baylor Scott & White Medical Center.

Dr. Collins' NPI, 1043465214, was assigned on December 1, 2008. Dr. Collins graduated from Jacobs School of Medicine and Biomedical Sciences in 2006. Dr. Collins' New York license number on file is 260570.

Dr. Collins' primary practice is Baylor Scott & White Medical Center - Frisco, at 5601 Warren Parkway, Frisco, TX 75034 in Denton County. The practice phone is (214) 407-5000.

Dr. Collins' primary practice is Baylor Scott & White Medical Center - Frisco in Frisco, Texas, part of Baylor Scott & White Medical Center. Dr. Collins is also affiliated with Baylor Scott & White Medical Center - McKinney. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Collins to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Collins practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Collins' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Collins is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Collins' licenses on file in 3 states: New York, Texas and Tennessee.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding, hemorrhoids, irritable bowel syndrome (IBS) and pancreas or bile duct endoscopy (ERCP) among the conditions Dr. Collins treats.

CMS data shows 418 Medicare services from Dr. Collins across 7 procedure codes in 2024, for 275 Medicare patients. Medicare paid $50,170 for them.

CMS counts 275 Medicare patients who saw Dr. Collins in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Collins' median patient age at 62, with 45% women.

In 2024, Dr. Collins wrote 780 Medicare Part D claims for 347 patients. 79% of them were for generic drugs. CMS names the drug for 677 of them, across 16 drugs with 11 or more claims each, at $89,238 in total drug cost. In 2023, CMS named 656 claims across 17 drugs.

Dr. Collins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Collins as offering telehealth. CMS counts 98 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Collins, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Collins, published from 2009 to 2011. The most frequent topics are Colorectal Neoplasms. Dr. Collins' most frequent co-authors are Hashem Beshir El-Serag, MD, MPH, Laura A. Petersen, MD and Hardeep Singh, MD.

CMS Open Payments shows 150 general payments to Dr. Collins from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $598.

Dr. Collins graduated from Jacobs School of Medicine and Biomedical Sciences in 2006.

Dr. Collins is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.